Sie befinden sich hier
Inhalt
The Mannheim Institute for Innate Immunoscience (MI3) of Heidelberg University serves as a cross-sectional hub for innovative immunology research with an emphasis on innate immunity. In close connection with the four research areas of the Medical Faculty Mannheim and the University Medical Center Mannheim, the MI3 explores the functions of innate immune cells and their tissue specific cross-talk with the adaptive immune system, non-immune and malignant cells and pathogens.
News
NK CELLS in CANCER THERAPY
Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity. Ni J, Wang X, Stojanovic A, Zhang Q, Wincher M, Bühler L, Arnold A, Correia MP, Winkler M, Koch PS, Sexl V, Höfer T, Cerwenka A. Immunity. 2020;52:1075.
Kick-Off Retreat
MI3 holds its opening retreat on March 5, 2020. The core and asscoiate members will convene to talk about the first interdisciplinary projects and the next milestones of the new research institute at the Medical Faculty Mannheim of Heidelberg University.
Kontextspalte
Core Members
Adelheid Cerwenka, Prof. Dr.
Director
Harald Klüter, Prof. Dr.
Thomas Miethke, Prof. Dr.
Michael Neumaier, Prof. Dr.
Co-Director
Georg Stoecklin, Prof. Dr. Dr.
Co-Director
Associate Members
Elke Burgermeister, PD. Dr.
Kai Doberstein, Dr.
Steven Dooley, Prof. Dr.
Matthias Ebert, Prof. Dr.
Sascha Gravius, Prof. Dr.
Jörg Heineke, Prof. Dr.
Stefan Klein, PD. Dr.
Bernhard Krämer, Prof. Dr.
Julia Kzhyshkowska, Prof. Dr.
Holger Lindner, PD Dr.
Jan Nicolay, Prof. Dr.
Michael Platten, Prof. Dr.
Lucas Schirmer, PD. Dr.
Astrid Schmieder, Prof. Dr.
Horst Schroten, Prof. Dr.
Christian Schwerk, Prof. Dr.
Jonathan Sleeman, Prof. Dr.
Marc Sütterlin, Prof. Dr.
Manfred Thiel, Prof. Dr.
Viktor Umansky, Prof. Dr
Benito Yard, Prof. Dr.